<DOC>
	<DOCNO>NCT01977768</DOCNO>
	<brief_summary>The purpose study identify optimally effective dose whole-cell , heat-killed Mycobacterium vaccae formulate pill consequently carry multi-country , placebo-controlled , randomized Phase III trial patient drug-sensitive , multi-drug resistant ( MDR-TB ) TB-HIV .</brief_summary>
	<brief_title>TB Immunotherapy Trial With Heat-killed M. Vaccae</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>confirm diagnosis TB sputum smear positive pregnant likely noncompliant due drug and/or alcohol abuse mentally unfit comply treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>M. vaccae</keyword>
	<keyword>TB</keyword>
	<keyword>MDR-TB</keyword>
	<keyword>V7-immunitor</keyword>
</DOC>